Conditions like A.D.H.D. and autism can make starting and completing tasks feel impossible, but experts say there are workarounds.

Busy Philipps and Ann Childress, MD, explore the unique challenges women face in ADHD diagnosis, highlighting personal stories and the importance of treatment.

[Excerpt] Bill S795 by Sen. Alana DiMario, a Narragansett Democrat, passed 36-0 and now joins the amended version of bill H5866 by Portsmouth Democratic Rep. Michelle McGaw, which passed the House 70-0 on April 22. Now each bill awaits a committee hearing in the opposite chamber. Both bills would allow for non-opioid Schedule II stimulants…

Consumer advocacy organization Public Citizen is sounding the alarm about potential risks for birth defects associated with modafinil (Provigil) and armodafinil (Nuvigil), two stimulants commonly prescribed during pregnancy. The group argued that animal toxicity studies and post-marketing observational studies have turned up sufficient evidence to justify additional precautions for pregnant patients.

Summary: New research identifies a promising strategy for correcting dopamine imbalances in the brain using a drug that blocks kappa opioid receptors (KOR). In mouse models with a rare mutation that causes dopamine to leak abnormally, KOR blockers reduced this leakage and restored normal behavior. This approach could offer safer treatment alternatives for conditions like…

[Excerpt] Researchers at the National Institutes of Health and King’s College London recently carried out a large-scale statistical analysis aimed at comparing the patterns of communication between different regions in the brains of individuals diagnosed with ASD with those observed in the brains of individuals with ADHD. Their findings, published in Nature Mental Health, suggest…

In a recent study published in the journal Nature Mental Health, researchers in the United States investigated and compared the genetic relationships and causal links between cannabis use, cannabis use disorder (CanUD), and a wide range of psychiatric disorders.

LOS ANGELES — The novel norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI) centanafadine (Otsuka Pharmaceutical Co., Ltd.) is effective and “clinically meaningful” for adult attention-deficit/hyperactivity disorder (ADHD), new research suggested. In a combined analysis of two phase 3 trials with a total of 859 adults, more patients who received the NDSRI had at least an…

Key Takeaways: An intervention for parents of children with both asthma and ADHD reduced unscheduled healthcare visits compared with usual care. Asthma control improved significantly, as did parent-rated ADHD symptoms. The study was limited by its focus on families in Hong Kong, with unknown generalizability to U.S. care settings.

In a recent review article published in the journal Scientific Reports, researchers systematically identified and analyzed existing research to explore the link between attention-deficit hyperactivity disorder (ADHD) and various intestinal disorders.

A new study published in the Journal of Psychiatric Research sheds light on the long-term challenges faced by individuals diagnosed with attention deficit hyperactivity disorder (ADHD). The research shows that adults with ADHD are more likely to struggle with education, employment, and overall social functioning compared to those without the condition.

A lack of reliable data tracking the prevalence and incidence of ADHD post-2020 has resulted in significant gaps in an evidence base to develop realistic health policy, according to new research from the Institute of Psychiatry, Psychology & Neuroscience